Portola Pharma (PTLA) Enters Expanded AndexXa Development Agreement iwth Daiichi Sankyo
Tweet Send to a Friend
Portola Pharmaceuticals Inc.® (Nasdaq: PTLA) announced that it has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE